| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000048070 |
| Receipt No. | R000054693 |
| Scientific Title | Efficacy and safety of Janus kinase 1 inhibitor for chronic pouchitis in patients with ulcerative colitis |
| Date of disclosure of the study information | 2022/07/01 |
| Last modified on | 2022/06/16 (Ver. 1) |
| Basic information | ||
| Public title | Efficacy and safety of filgotinib for refractory pouchitis in patients with ulcerative colitis | |
| Acronym | Efficacy of filgotinib for pouchitis | |
| Scientific Title | Efficacy and safety of Janus kinase 1 inhibitor for chronic pouchitis in patients with ulcerative colitis | |
| Scientific Title:Acronym | Efficacy of Janus kinase 1 inhibitor for pouchitis | |
| Region |
|
|
| Condition | |||
| Condition | ulcerative colitis, pouchitis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Efficacy of filgochinib for pouchitis |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | imprpvement by using modified pouchitis activity index with treatment.(Evaluations will be performed after 12weeks and 54 weeks of induction. |
| Key secondary outcomes | Incidence and kinds of adverse events during treatment.
Secession from antibiotics use. Alteration of antibiotics dosage. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Treatment with filgochinib | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Anti-biotics dependent or refractory pouchitis. | |||
| Key exclusion criteria | Patients who dose not agree the treatment with filgochinib. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hyogo medical university | ||||||
| Division name | Department of Gastroenterological surgery | ||||||
| Zip code | 6638501 | ||||||
| Address | 1-1 Mukogawacho, Nshinomiya city, Hyogo pref | ||||||
| TEL | 0798456371 | ||||||
| ikeuci2s@hyo-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hyogo medical university | ||||||
| Division name | Department of Gastroenterological surgery | ||||||
| Zip code | 6638501 | ||||||
| Address | 1-1 Mukogawacho, Nshinomiya city, Hyogo pref | ||||||
| TEL | 0798456371 | ||||||
| Homepage URL | |||||||
| uchino2s@hyo-med.ac.jp | |||||||
| Sponsor | |
| Institute | Hyogo medical university
Department of Gastroenterological Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Gastroenterological Surgery,
Hyogo Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hyogo medical university |
| Address | 1-1 Mukogawacho, Nishinomiya, Hyogo |
| Tel | 0798456371 |
| uchino2s@hyo-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054693 |